244 related articles for article (PubMed ID: 15034726)
1. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
[TBL] [Abstract][Full Text] [Related]
2. [Operative case of isomorphic astrocytoma].
Matsuda K; Sakurada K; Mouri W; Saino M; Sato S; Saito S; Kayama T; Nakazato Y
Brain Nerve; 2007 Aug; 59(8):881-6. PubMed ID: 17713125
[TBL] [Abstract][Full Text] [Related]
3. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
4. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.
Luyken C; Blümcke I; Fimmers R; Urbach H; Wiestler OD; Schramm J
Cancer; 2004 Jul; 101(1):146-55. PubMed ID: 15222000
[TBL] [Abstract][Full Text] [Related]
5. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
Schramm J; Luyken C; Urbach H; Fimmers R; Blümcke I
Neurosurgery; 2004 Aug; 55(2):340-7; discussion 347-8. PubMed ID: 15271240
[TBL] [Abstract][Full Text] [Related]
8. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.
Torp SH
Clin Neuropathol; 2002; 21(6):252-7. PubMed ID: 12489673
[TBL] [Abstract][Full Text] [Related]
11. Tumor recurrence and malignant progression of gangliogliomas.
Majores M; von Lehe M; Fassunke J; Schramm J; Becker AJ; Simon M
Cancer; 2008 Dec; 113(12):3355-63. PubMed ID: 18988291
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife surgery for low-grade astrocytomas: evaluation of long-term outcome based on a 10-year experience.
Wang LW; Shiau CY; Chung WY; Wu HM; Guo WY; Liu KD; Ho DM; Wong TT; Pan DH
J Neurosurg; 2006 Dec; 105 Suppl():127-32. PubMed ID: 18503345
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
[TBL] [Abstract][Full Text] [Related]
14. Ceramide levels are inversely associated with malignant progression of human glial tumors.
Riboni L; Campanella R; Bassi R; Villani R; Gaini SM; Martinelli-Boneschi F; Viani P; Tettamanti G
Glia; 2002 Aug; 39(2):105-13. PubMed ID: 12112362
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
16. Oligoastrocytoma presenting with intractable epilepsy.
Hiremath GK; Bingaman WE; Prayson RA; Nair D
Epileptic Disord; 2007 Sep; 9(3):315-22. PubMed ID: 17884756
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic volumetric resection of thalamic pilocytic astrocytomas.
Moshel YA; Link MJ; Kelly PJ
Neurosurgery; 2007 Jul; 61(1):66-75; discussion 75. PubMed ID: 17621020
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.
Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q
J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
20. [Pleomorphic xanthoastrocytoma].
Vajtai I; Varga Z
Orv Hetil; 1997 Apr; 138(16):991-7. PubMed ID: 9190551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]